[go: up one dir, main page]

JP2010285387A - Norovirus inactivating agent - Google Patents

Norovirus inactivating agent Download PDF

Info

Publication number
JP2010285387A
JP2010285387A JP2009141526A JP2009141526A JP2010285387A JP 2010285387 A JP2010285387 A JP 2010285387A JP 2009141526 A JP2009141526 A JP 2009141526A JP 2009141526 A JP2009141526 A JP 2009141526A JP 2010285387 A JP2010285387 A JP 2010285387A
Authority
JP
Japan
Prior art keywords
norovirus
mass
inactivating agent
effect
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009141526A
Other languages
Japanese (ja)
Other versions
JP5377098B2 (en
Inventor
Yasunobu Fukuda
泰伸 福田
Kazuyuki Sugamoto
和志 菅本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainihon Jochugiku Co Ltd
Original Assignee
Dainihon Jochugiku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainihon Jochugiku Co Ltd filed Critical Dainihon Jochugiku Co Ltd
Priority to JP2009141526A priority Critical patent/JP5377098B2/en
Publication of JP2010285387A publication Critical patent/JP2010285387A/en
Application granted granted Critical
Publication of JP5377098B2 publication Critical patent/JP5377098B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a norovirus deactivator which is effective for normal viruses including influenza viruses and noroviruses having no envelope as well and has high safety. <P>SOLUTION: The norovirus deactivator comprises 0.01-5.0 mass% 1,4-bis[3,3'-(1-decylpyridinium)methyloxy]butane dibromide (a), 20-60 mass% lower alcohol (b), and water (c) and is compounded with 0.01-2.0 mass% plant extract deodorant (d). More preferably, the plant extract deodorant (d) is a sugar cane extract. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、ノロウイルス不活性化剤に関するものである。 The present invention relates to a norovirus inactivating agent.

大腸菌O−157による食中毒事件の多発に始まり、その後、新型肺炎SARSが猛威を振い、ここ数年はノロウイルスによる食中毒が多発している。2009年の春には新型インフルエンザが発生してパンデミック寸前の状態になり、除菌衛生に対する関心は高まる一方である。
大腸菌O−157による食中毒事件が多発した1996年以降、多くの家庭用品で抗菌性が付与されており、使用される薬剤としては、銀、銅などの金属化合物を利用したものが多い。例えば、銀ブロム又はヨード錯体の塩を含有する抗菌性繊維(特許文献1:特開2008−338481号公報)が知られているが、その防カビ効果は小さく、ウイルスに対する効果も十分でない。
Beginning with frequent occurrences of food poisoning caused by Escherichia coli O-157, the new type of pneumonia SARS has been rampant, and food poisoning due to norovirus has been frequent in recent years. In the spring of 2009, an outbreak of new influenza was on the verge of a pandemic, and interest in sanitary sanitation is increasing.
Since 1996, when many cases of food poisoning due to E. coli O-157 occurred frequently, many household products have been given antibacterial properties, and many of the drugs used use metal compounds such as silver and copper. For example, although an antibacterial fiber containing a salt of silver bromide or an iodine complex (Patent Document 1: Japanese Patent Application Laid-Open No. 2008-338481) is known, its antifungal effect is small and the effect on viruses is not sufficient.

一方、抗ウイルス剤もしくは抗ウイルス効果を謳った製品も、いくつか提案されている。例えば、少なくとも一箇所にフェノール性水酸基を有する、非水溶性の芳香族ヒドロキシ化合物を有効成分とする抗ウイルス剤を塗布あるいは混合させてなる繊維(特許文献2:特開2005―112748号公報)、濾材の少なくとも1層に水酸基とカルボキシル基を同時に有するヒドロキシ酸が含有されてなる抗ウイルスマスク(特許文献3:特開2005−198676号公報)、ポリ−オキシエチレン(ジメチルイミノ)エチレン(ジメチルイミノ)エチレンジクロライドを含有する繊維用抗ウイルス加工剤(特許文献4:特開2008−115506号公報)、2−ピリジンチオール亜鉛−1−オキシド、2−ピリジンチオール銅−1−オキシド、又はこれらの両方を含む抗ウイルス剤で処理された抗ウイルス性繊維(特許文献5:特開2009−7736号公報)等が知られている。 On the other hand, some antiviral agents or products with an antiviral effect have been proposed. For example, a fiber formed by applying or mixing an antiviral agent having a water-insoluble aromatic hydroxy compound having a phenolic hydroxyl group in at least one place as an active ingredient (Patent Document 2: JP-A-2005-112748), Antiviral mask (Patent Document 3: Japanese Patent Laid-Open No. 2005-198676), poly-oxyethylene (dimethylimino) ethylene (dimethylimino), wherein at least one layer of the filter medium contains a hydroxy acid having a hydroxyl group and a carboxyl group at the same time An antiviral processing agent for fibers containing ethylene dichloride (Patent Document 4: JP 2008-115506 A), 2-pyridinethiol zinc-1-oxide, 2-pyridinethiol copper-1-oxide, or both Antiviral fiber treated with antiviral agent containing (Patent Document 5 JP 2009-7736 JP), and the like.

ところで、特許文献6(特開2008−214268号公報)は、分子末端に2個のピリジン環またはキノリン環を有し、該ピリジン環またはキノリン環の窒素原子が第4級アンモニウム基となっている抗ウイルス剤を開示する。しかしながら、特許文献6に記載されている抗ウイルス効果は、インフルエンザウイルスに対する効果に留まり、ノロウイルスに効果があるとの記載はない。
ノロウイルスは、エンベロープを持たないウイルスであり、通常の抗ウイルス剤はインフルエンザウイルスに有効でもノロウイルスに効きにくいというのが従来の知見であった。
By the way, Patent Document 6 (Japanese Patent Laid-Open No. 2008-214268) has two pyridine rings or quinoline rings at the molecular ends, and the nitrogen atom of the pyridine ring or quinoline ring is a quaternary ammonium group. Antiviral agents are disclosed. However, the antiviral effect described in Patent Document 6 is limited to the effect against influenza virus, and there is no description that it is effective against norovirus.
Norovirus is a virus that does not have an envelope, and it has been a conventional finding that ordinary antiviral agents are effective against influenza viruses but are less effective against noroviruses.

従って、ノロウイルスを不活性化しようとすると、煮沸や塩素系消毒剤の使用に頼るしかなかったが、反応性の高い酸化剤である塩素系薬剤は、安全性の点で問題が多いし、例えば、繊維処理に用いることは技術的にも難しい。
最近の特許文献7(特開2008−189645号公報)によれば、低級アルコール、アルカリ性物質及びカチオン界面活性剤を含む組成物がノロウイルスに有効である旨開示されているが、この組成物にしても、アルカリ性物質を使用するため、安全性に対する危惧は避けられない。
このように、安全性が高くかつノロウイルスに有効なノロウイルス不活性化剤は未だ知られていない。
本発明者らは、特許文献6の一般式に包含される化合物群のうち、1,4―ビス(3,3’―(1―デシルピリジニウム)メチルオキシ)ブタンジブロマイドに着目し、この化合物がインフルエンザウイルスのみならず、ノロウイルスに対しても特異的に有効であることを知見して本発明を完成するに至ったものである。
Therefore, in order to inactivate norovirus, we had to rely on boiling or the use of chlorinated disinfectants, but chlorinated drugs that are highly reactive oxidizing agents have many problems in terms of safety, for example, It is technically difficult to use for fiber processing.
According to recent patent document 7 (Japanese Patent Laid-Open No. 2008-189645), it is disclosed that a composition containing a lower alcohol, an alkaline substance and a cationic surfactant is effective for norovirus. However, since alkaline substances are used, there is an unavoidable concern about safety.
Thus, norovirus inactivating agents that are highly safe and effective for norovirus have not yet been known.
The present inventors pay attention to 1,4-bis (3,3 ′-(1-decylpyridinium) methyloxy) butanedibromide among the compounds included in the general formula of Patent Document 6, and this compound Has been found to be specifically effective against not only influenza viruses but also noroviruses, and the present invention has been completed.

特開2008−338481号公報JP 2008-338481 A 特開2005―112748号公報JP-A-2005-112748 特開2005−198676号公報JP 2005-198676 A 特開2008−115506号公報JP 2008-115506 A 特開2009−7736号公報JP 2009-7736 A 特開2008−214268号公報JP 2008-214268 A 特開2008−189645号公報JP 2008-189645 A

本発明は、安全性が高くかつノロウイルスに有効なノロウイルス不活性化剤を提供することを目的とする。 An object of the present invention is to provide a norovirus inactivating agent that is highly safe and effective for norovirus.

本発明は、以下の構成が上記目的を達成するために優れた効果を奏することを見出したものである。
(1)(a)1,4―ビス(3,3’―(1―デシルピリジニウム)メチルオキシ)ブタンジブロマイドを0.01〜5.0質量%と、(b)低級アルコールを20〜60質量%と、(c)水を配合したノロウイルス不活性化剤。
(2)更に、(d)植物抽出消臭剤を0.01〜2.0質量%配合した(1)記載のノロウイルス不活性化剤。
(3)前記(d)植物抽出消臭剤がサトウキビエキスである(2)記載のノロウイルス不活性化剤。
The present invention has been found that the following constitution has an excellent effect for achieving the above-mentioned object.
(1) 0.01-5.0% by mass of (a) 1,4-bis (3,3 ′-(1-decylpyridinium) methyloxy) butanedibromide, and (b) 20-60 of a lower alcohol A norovirus inactivating agent containing mass% and (c) water.
(2) The norovirus inactivating agent according to (1), further comprising (d) 0.01 to 2.0% by mass of a plant extraction deodorant.
(3) The norovirus inactivating agent according to (2), wherein the (d) plant extraction deodorant is sugarcane extract.

本発明のノロウイルス不活性化剤は、安全性が高くかつノロウイルスに優れた効果を示すので非常に有用である。 The norovirus inactivating agent of the present invention is very useful because it is highly safe and exhibits an excellent effect on norovirus.

本発明で用いる化合物、1,4―ビス(3,3’―(1―デシルピリジニウム)メチルオキシ)ブタンジブロマイド[以降、化合物Aと称す]は、特許文献6の一般式に包含され、抗ウイルス剤として公知であるが、本発明者らは鋭意試験を繰り返し、化合物Aが特許文献6の化合物群のなかでも特異的に、インフルエンザウイルスのみならずノロウイルスに対しても効果を奏することを新たに見出したのである。
化合物Aは、本発明のノロウイルス不活性化剤中に0.01〜5.0質量%配合される。0.01質量%より少ないと確実な効果が得られないし、一方、5.0質量%を超えると製剤の物性に影響を及ぼす恐れがある。コスト、安全性等を考慮し、0.05〜1.0質量%の配合が好ましい。
The compound used in the present invention, 1,4-bis (3,3 ′-(1-decylpyridinium) methyloxy) butanedibromide [hereinafter referred to as Compound A], is included in the general formula of Patent Document 6, Although known as a virus agent, the present inventors have repeated intensive studies, and it has been renewed that Compound A is effective not only for influenza virus but also for norovirus in the compound group of Patent Document 6. I found it.
Compound A is blended in an amount of 0.01 to 5.0% by mass in the norovirus inactivating agent of the present invention. If the amount is less than 0.01% by mass, a certain effect cannot be obtained. On the other hand, if it exceeds 5.0% by mass, the physical properties of the preparation may be affected. In consideration of cost, safety, etc., 0.05 to 1.0% by mass is preferable.

また、ノロウイルス不活性化剤は、低級アルコールを20〜60質量%と水の配合を必須とする。低級アルコールとしては、エタノールやイソプロパノールがあげられるが、細菌、カビ、ウイルスに対する即効性を付与する効果を考慮して、エタノールが好ましい。エタノールの使用は、例えば、繊維製品に噴霧処理した時にノロウイルス不活性化剤が速やかに乾燥しベタツキを生じないというメリットも有する。
なお、水は化合物Aの溶解剤として配合される。
In addition, the norovirus inactivating agent requires the blending of 20-60 mass% of lower alcohol and water. Examples of the lower alcohol include ethanol and isopropanol, and ethanol is preferable in consideration of the effect of imparting immediate effects on bacteria, molds and viruses. The use of ethanol also has an advantage that, for example, when a fiber product is sprayed, the norovirus inactivating agent is quickly dried and does not cause stickiness.
Water is added as a solubilizer for compound A.

本発明では、更に、植物抽出消臭剤を0.01〜2.0質量%を配合するのが好ましい。即ち、植物抽出消臭剤は、試験の結果、消臭効果だけでなく、化合物Aのノロウイルス不活性化作用を助長することが見出され、併用することによって、より優れた組成物が提供される。
かかる植物抽出消臭剤としては、サトウキビエキス、緑茶抽出エキス、チャ乾留物、柿抽出エキス、グレープフルーツ抽出エキス、モウゾウチク抽出エキス、ユズ種子抽出エキス、レンギョウ抽出エキス等があげられるが、なかんずくサトウキビエキスが好適である。
In this invention, it is preferable to mix | blend 0.01-2.0 mass% of plant extraction deodorizers further. That is, as a result of the test, the plant-extracted deodorant was found to promote not only the deodorizing effect but also the norovirus inactivating action of Compound A, and by using it together, a more excellent composition is provided. The
Examples of such a plant extract deodorant include sugarcane extract, green tea extract, tea dried product, koji extract, grapefruit extract extract, mozochiku extract extract, yuzu seed extract, forsythia extract, etc. Is preferred.

本発明のノロウイルス不活性化剤には、更に、抗菌効果、防藻効果、あるいは防錆効果、洗浄効果、撥水効果、防汚効果等を付与するために、銀系、銅系等の無機抗菌剤やポリリジン、キトサン等の有機抗菌剤、防藻剤、防錆剤、界面活性剤、撥水剤、防汚剤、溶剤等を適宜配合したり、あるいは、香料等を配合して芳香性を付与するようにしてもよい。 The norovirus inactivating agent of the present invention is further provided with an inorganic such as a silver-based or copper-based in order to impart an antibacterial effect, an algal control effect, or a rust preventive effect, a cleaning effect, a water repellent effect, an antifouling effect, and the like. Organic antibacterial agent such as antibacterial agent, polylysine, chitosan, algae proofing agent, rust preventive agent, surfactant, water repellent agent, antifouling agent, solvent etc. are blended as appropriate, or fragrance etc. are blended to be aromatic May be given.

こうして得られた本発明のノロウイルス不活性化剤は、安全性に優れたものであり、台所、流し台、冷蔵庫等の食品を取り扱う場所、居室や寝室、トイレ等の居住空間、ソファー、クッション、寝具、カーテン、マスク等の繊維製品等の処理に効果的で有用性が高い。 The norovirus inactivating agent of the present invention thus obtained is excellent in safety and is used for food handling such as kitchens, sinks, refrigerators, living spaces such as living rooms and bedrooms, toilets, sofas, cushions, bedding It is effective and highly useful for treating textile products such as curtains and masks.

ノロウイルスの不活性化処理に際しては、本発明のノロウイルス不活性化剤を、トリガースプレイヤーやボタン付きディスペンサーを備えたボトルに収容するか、もしくはエアゾールとして、随時、必要に応じて噴霧すればよい。
なお、本発明のノロウイルス不活性化剤の処理量は、1m2あたり化合物Aとして、0.01〜2.0g程度が適当である。
In the inactivation treatment of norovirus, the norovirus inactivating agent of the present invention may be contained in a bottle equipped with a trigger sprayer or a dispenser with a button, or may be sprayed as needed as an aerosol.
In addition, the processing amount of the norovirus inactivating agent of the present invention is suitably about 0.01 to 2.0 g as Compound A per 1 m 2 .

次に、具体的な実施例に基づき、本発明のノロウイルス不活性化剤について更に詳細に説明するが、本発明はこれらに限定されるものではない。 Next, the norovirus inactivating agent of the present invention will be described in more detail based on specific examples, but the present invention is not limited thereto.

表1に示す組成の実施品並びに比較品の試験液を作製し、以下の抗ウイルス試験に供した。なお、化合物Bは、塩化ベンザルコニウムである。 Test solutions of the practical products and comparative products having the compositions shown in Table 1 were prepared and subjected to the following antiviral tests. Compound B is benzalkonium chloride.

[試験1:インフルエンザウイルス及びノロウイルスに対するウイルス不活性化試験]
各試験液1mlにウイルス浮遊液0.1mlを滴下し、室温で30分後のウイルス感染価の低下を調べた。ウイルス感染価はウイルス浮遊液を接種した培養細胞の形態変化を観察し、50%組織培養感染量から算出した。
また、ノロウイルスに対する効果は、ノロウイルスに対する代替ウイルスとして広く使用されているネコカリシウイルスを用いた。結果を表2に示す。
[Test 1: Virus inactivation test against influenza virus and norovirus]
0.1 ml of the virus suspension was dropped into 1 ml of each test solution, and the decrease in virus infectivity after 30 minutes at room temperature was examined. The virus infectivity titer was calculated from the 50% tissue culture infectious dose by observing morphological changes of cultured cells inoculated with the virus suspension.
Moreover, the effect with respect to a norovirus used the feline calicivirus widely used as an alternative virus with respect to a norovirus. The results are shown in Table 2.

本発明の実施品では、すべて、ノロウイルスに対して効果があり、なかでも、サトウキビ抽出エキスあるいは緑茶抽出エキスを配合した実施品3及び4の効果が高かった。一方、化合物Aを含まないか、あるいは、低濃度しか含有しない比較例1及び3では、ノロウイルスに対して全く無効であった。また、化合物Aを含有しても、エタノールを配合しない比較例2の場合、ノロウイルスに対する不活性化効果は満足のいくものでなかった。 The products of the present invention were all effective against norovirus, and in particular, the effects of the products 3 and 4 containing the sugarcane extract or the green tea extract were high. On the other hand, Comparative Examples 1 and 3 containing no compound A or containing only a low concentration were completely ineffective against norovirus. Even in the case of Comparative Example 2 in which ethanol was not blended even when compound A was contained, the inactivation effect against norovirus was not satisfactory.

実施品3の本発明ノロウイルス不活性化剤を、1回当りの噴射量が1gのトリガースプレイヤー付き容器に充填し、マスク、スーツ、スカート、セーター、肌着、カーペット、ソファー、スリッパなどの繊維製品に噴霧処理したところ、染みや皺が発生せず、簡便・容易にノロウイルス不活性化効果を付与できた。また、台所のテーブル、流し台、まな板、冷蔵庫、トイレの便器、便座、ドアノブ、浴室の壁、天井に噴霧処理したときも、材質に対する影響がなく、同様に優れたノロウイルス不活性化効果が得られた。
このように、本発明のノロウイルス不活性化剤は、簡便・容易にノロウイルス不活性化処理を行うことが可能で、極めて実用性の高いものであった。
Filling the container with trigger sprayer of 1g of the injection amount of the present invention Norovirus of execution product 3 into 1g, textile products such as mask, suit, skirt, sweater, underwear, carpet, sofa, slippers, etc. As a result of spraying, no stain or wrinkle was produced, and a norovirus inactivating effect could be easily and easily imparted. In addition, when spraying on kitchen tables, sinks, cutting boards, refrigerators, toilet bowls, toilet seats, door knobs, bathroom walls and ceilings, there is no effect on the material, and excellent norovirus inactivation effect is obtained as well. It was.
As described above, the norovirus inactivating agent of the present invention can be easily and easily subjected to norovirus inactivation treatment, and is extremely practical.

本発明は、抗菌、抗ウイルスなど保健衛生分野で須らく利用可能である。
The present invention can be used effectively in the field of health and hygiene such as antibacterial and antiviral.

Claims (3)

(a)1,4―ビス(3,3’―(1―デシルピリジニウム)メチルオキシ)ブタンジブロマイドを0.01〜5.0質量%と、(b)低級アルコールを20〜60質量%と、(c)水を配合したことを特徴とするノロウイルス不活性化剤。 (A) 0.01-5.0% by mass of 1,4-bis (3,3 ′-(1-decylpyridinium) methyloxy) butanedibromide and (b) 20-60% by mass of lower alcohol (C) Norovirus inactivating agent characterized by containing water. 更に、(d)植物抽出消臭剤を0.01〜2.0質量%配合したことを特徴とする請求項1記載のノロウイルス不活性化剤。 Furthermore, (d) 0.01-2.0 mass% of plant extraction deodorants were mix | blended, The norovirus inactivating agent of Claim 1 characterized by the above-mentioned. 前記(d)植物抽出消臭剤がサトウキビエキスであることを特徴とする請求項2記載のノロウイルス不活性化剤。




The norovirus inactivating agent according to claim 2, wherein the (d) plant extract deodorant is sugarcane extract.




JP2009141526A 2009-06-12 2009-06-12 Norovirus inactivating agent Active JP5377098B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009141526A JP5377098B2 (en) 2009-06-12 2009-06-12 Norovirus inactivating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009141526A JP5377098B2 (en) 2009-06-12 2009-06-12 Norovirus inactivating agent

Publications (2)

Publication Number Publication Date
JP2010285387A true JP2010285387A (en) 2010-12-24
JP5377098B2 JP5377098B2 (en) 2013-12-25

Family

ID=43541372

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009141526A Active JP5377098B2 (en) 2009-06-12 2009-06-12 Norovirus inactivating agent

Country Status (1)

Country Link
JP (1) JP5377098B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014198070A (en) * 2013-03-29 2014-10-23 株式会社ソフト99コーポレーション Perfume microcapsule-containing aromatic deodorant
JP2020062199A (en) * 2018-10-17 2020-04-23 アルケア株式会社 Ostomy prosthesis lubricating deodorant composition
JP2021120417A (en) * 2017-02-06 2021-08-19 大日本除蟲菊株式会社 Virus deactivation composition
JP2022016360A (en) * 2020-07-10 2022-01-21 大阪化成株式会社 Antibacterial/antiviral composition and antibacterial/antiviral fiber product

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008179571A (en) * 2007-01-25 2008-08-07 Aquas Corp Microbial control agent and microorganism control method
JP2008189645A (en) * 2007-02-01 2008-08-21 Saraya Kk Composition effective for inactivation of hydrophilic virus
JP2008214268A (en) * 2007-03-05 2008-09-18 Tama Kagaku Kogyo Kk Antiviral agent
JP2010215598A (en) * 2009-03-19 2010-09-30 Diversey Co Ltd Virucidal agent composition for calicivirus and method of application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008179571A (en) * 2007-01-25 2008-08-07 Aquas Corp Microbial control agent and microorganism control method
JP2008189645A (en) * 2007-02-01 2008-08-21 Saraya Kk Composition effective for inactivation of hydrophilic virus
JP2008214268A (en) * 2007-03-05 2008-09-18 Tama Kagaku Kogyo Kk Antiviral agent
JP2010215598A (en) * 2009-03-19 2010-09-30 Diversey Co Ltd Virucidal agent composition for calicivirus and method of application thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014198070A (en) * 2013-03-29 2014-10-23 株式会社ソフト99コーポレーション Perfume microcapsule-containing aromatic deodorant
JP2021120417A (en) * 2017-02-06 2021-08-19 大日本除蟲菊株式会社 Virus deactivation composition
JP2020062199A (en) * 2018-10-17 2020-04-23 アルケア株式会社 Ostomy prosthesis lubricating deodorant composition
JP2022016360A (en) * 2020-07-10 2022-01-21 大阪化成株式会社 Antibacterial/antiviral composition and antibacterial/antiviral fiber product

Also Published As

Publication number Publication date
JP5377098B2 (en) 2013-12-25

Similar Documents

Publication Publication Date Title
CN101500418B (en) Method of inhibiting the transmission of influenza virus
EP3500102B1 (en) Anti-microbial composition
JP2009173641A (en) Bactericidal disinfectant composition, bactericidal disinfectant material comprising the same, and bactericidal disinfection method using the same composition or the same material
JP2009292736A (en) Anti-norovirus composition
Ezzatpanah et al. New food safety challenges of viral contamination from a global perspective: Conventional, emerging, and novel methods of viral control
WO2011044916A1 (en) Multipurpose eco-friendly disinfecting composition comprising nano size antibacterial agent
JP2019052107A (en) Bactericidal and virus inactivation agent and bactericidal and virus inactivation method
JP5377098B2 (en) Norovirus inactivating agent
JP7705762B2 (en) Antiviral, disinfectant and cleaning agents
JP2025175100A (en) Virus inactivator composition, method for enhancing virus inactivation efficacy, and virus inactivation method
CN110477792A (en) A kind of nonalcoholic wet tissue and preparation method thereof can be used for breathing mask cleaning-sterilizing
JP5637525B2 (en) Antiviral treatment method for textile products
JP6262434B2 (en) Antibacterial spray composition for skin wear
WO2022038630A1 (en) Surface cleaning composition and use thereof
JPH072615A (en) Cloth impregnated with antimicrobial disinfectant
JP6507345B2 (en) Composition for antiviral
JP7509380B2 (en) Virus inactivation preparations
JP5581030B2 (en) Formulation composition
CN104106599A (en) An aqueous disinfecting or sterilizing composition
JP7421903B2 (en) Virus inactivator composition
TW201805026A (en) Anti-mold agent composition, anti-mold spray product and anti-mildew method
JP7743956B2 (en) Novel coronavirus (SARS-CoV-2) inactivating composition
JP5974043B2 (en) Formulation composition
JP2011073982A (en) Compounded composition
JP2009274971A (en) Spray agent for preventing norovirus infection

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120515

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130731

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130813

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130828

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130924

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130924

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5377098

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250